Search Results
Jun 30, 2026, 09:03 ET Aspen Neuroscience Announces Completion of Cohort 3 and 4 Dosing in Aspiro Phase 1/2a Trial of Sasineprocel for Parkinson's Disease
beginning with neurodegenerative diseases of high unmet need including PD.Its lead product candidate is sasineprocel (ANPD001), the most advanced autologous investigational cell therapy in the United States for treating PD.About SasineprocelSasineprocel is a
More news about: Aspen Neuroscience, Inc.
Jun 30, 2026, 02:53 ET New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026
assessing clinical progression in people with cognitive impairment related to α-synuclein pathology will be discussed, primarily across Parkinson's disease (PD), Parkinson's disease dementia (PDD), and dementia with Lewy bodies (DLB).Key oral lecanemab presentations at AAICSubcutaneous
More news about: BioArctic
Jun 30, 2026, 02:44 ET New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026
assessing clinical progression in people with cognitive impairment related to α-synuclein pathology will be discussed, primarily across Parkinson's disease (PD), Parkinson's disease dementia (PDD), and dementia with Lewy bodies (DLB).Key oral lecanemab presentations at AAICSubcutaneous
More news about: BioArctic
Jun 30, 2026, 01:49 ET WuXi Biologics Receives Brazil ANVISA GMP Certification to Enable Global Commercial Manufacturing of Innovative Cancer Immunotherapy
certification positions WuXi Biologics to provide end‑to‑end commercial manufacturing services — covering both drug substance and drug product — for an anti-PD-L1 monoclonal antibody used in cancer immunotherapy. Based on the five-day inspection, MFG2, DP1 and DPPC successfully passed ANVISA's assessment
More news about: WuXi Biologics
Jun 29, 2026, 10:24 ET LG reforça benefícios da linha LG UltraFine para profissionais criativos
LG UltraFine™ Nano IPS Black 5K2K WUHD 40", Thunderbolt™ 5 96W PD, DisplayHDR™600, DCI-P3 99%(Typ.), USB-C, DP 2.1 - 40U990A-W | LG BrasilResumo da NotíciaA LG Electronics detalha
More news about: LG Electronics Brasil
Jun 29, 2026, 10:00 ET Make the Most of Summer Moments: Aurzen Transforms Backyards and Campsites into Open-Air Stadiums
wall-to-ceiling rotation flexibility, letting you project the match perfectly onto a roll-out RV awning or a tent wall. Both models feature a 65W USB-C PD port to run seamlessly off power banks or laptop chargers. For a completely untethered setup, they can be paired with the cordless
More news about: Aurzen
Jun 29, 2026, 08:30 ET Erayak Expands U.S. Online Retail Footprint as Backup Power Demand Shifts Toward Connected and AI-Enabled Endpoint Devices
previously discussed 6800PD/6800PT series has moved from product roadmap planning into market introduction. The 6800 series is designed to serve customers seeking higher-capacity inverter generator solutions for home backup, RV applications, and 120V/240V power needs. The 6800PD is positioned as a dual-fuel
More news about: Erayak Power Solution Group Inc.
Jun 29, 2026, 08:00 ET DJI 發表全新雙主鏡頭口袋電影機Osmo Pocket 4P：靈眸成雙，遠見非凡
4P 主相機、補光燈、1/4″ 螺紋手把、便攜收納袋、USB-C 至 USB-C PD 快充線（USB 3.1）等配件。Osmo Pocket 4P Vlog 套裝售價 HK$5,329/NT$21,790，內含 Osmo Pocket 4P 主相機、DJI Mic Mini 2 發射器、補光燈、取景遙控器、迷你三腳架、1/4″ 螺紋手把、收納包、便攜收納袋、USB-C 至 USB-C PD 快充線（USB 3.1）等配件。適用於 Osmo Pocket
More news about: DJI
Jun 29, 2026, 08:00 ET Alebund Pharmaceuticals (09637.HK) Debuts on the HKEx Main Board
safety and was well tolerated in healthy volunteers as well as in patients with DKD, and there was a clear and robust dose-dependent pharmacodynamic ("PD") signal. Alebund has received IND clearance from the NMPA and the FDA for AP303, and expects to conduct a basket Phase II clinical trial in DKD and
More news about: Alebund Pharmaceuticals
Jun 26, 2026, 10:30 ET Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted
therapeutic benefits and bleeding risks of antiplatelet medications.A series of completed clinical studies, including Phase I, Phase II, China-US PK/PD bridging study and Phase III trials, have fully validated the clinical efficacy and safety of Sumecigrel Capsule. It boasts multiple advantages
More news about: Jiangsu Vcare Pharmatech Co., Ltd.
Jun 26, 2026, 09:00 ET Novo Nordisk to showcase new data across its hemophilia portfolio at the ISTH Congress 2026, featuring investigational denecimig
presentation: Concizumab prophylaxis in paediatric participants with haemophilia A/B with inhibitors in the phase 3 explorer10 study: Efficacy, safety and PK/PD results from the 32-week cut-off
More news about: Novo Nordisk
Jun 26, 2026, 09:00 ET Novo Nordisk to showcase new data across its hemophilia portfolio at the ISTH Congress 2026, featuring investigational denecimig
presentation: Concizumab prophylaxis in paediatric participants with haemophilia A/B with inhibitors in the phase 3 explorer10 study: Efficacy, safety and PK/PD results from the 32-week cut-off
More news about: Novo Nordisk
Jun 26, 2026, 08:00 ET Ahead of First National Parkinson's Project Advisory Council Meeting, Leading Parkinson's Organizations Call for Urgent Action
Parkinson Disease Association (APDA) is a nonprofit organization dedicated to fighting Parkinson's disease (PD) by providing the support, education, research, and community that helps everyone impacted by PD live life to the fullest. Through a nationwide grassroots network of Chapters and Information &
More news about: The Michael J. Fox Foundation for Parkinson's Research
Jun 25, 2026, 14:15 ET Tigerlily Foundation Celebrates FDA Approval of Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer
part on a patient's PD-L1 status.PD-L1 is a biomarker that can help determine whether a patient may benefit from certain immunotherapy-based treatments. Patients with PD-L1 positive disease may be eligible for immunotherapy combinations, while patients whose tumors are PD-L1 negative — or who
More news about: TIGERLILY FOUNDATION
Jun 25, 2026, 12:36 ET Constructor Named a Leader in Gartner® Magic Quadrant™ for Search and Product Discovery -- Placing Furthest in Vision and Highest in Execution
rising popularity of digital commerce." It further notes: "Demand for differentiating S&PD continues to grow, especially with the shift toward GenAI platforms and the return of conversational commerce. A dedicated S&PD product is often seen as a relatively cost-effective way to provide optimal digital
More news about: Constructor
Jun 25, 2026, 09:25 ET Engenheiro da Zoomlion compartilha a história de P&D por trás de escavadeira no Oriente Médio reconhecida na sétima Conferência de Inovação Tecnológica
multimedia:https://www.prnewswire.com/br/comunicados-para-a-imprensa/engenheiro-da-zoomlion-compartilha-a-historia-de-pd-por-tras-de-escavadeira-no-oriente-medio-reconhecida-na-setima-conferencia-de-inovacao-tecnologica-302810761.htmlFONTE
More news about: Zoomlion
Jun 25, 2026, 05:44 ET CStone Pharmaceuticals Enters into Exclusive Commercialization Agreement with Arrotex for Sugemalimab across Australia and New Zealand
indications."About SugemalimabThe anti-PD-L1 monoclonal antibody sugemalimab was developed by CStone using OmniRat® transgenic animal platform, which allows creation of fully human antibodies in one step. Sugemalimab is a fully human, full-length anti-PD-L1 immunoglobulin G4 (IgG4) monoclonal
More news about: CStone Pharmaceuticals
Jun 24, 2026, 22:54 ET CARsgen、固形がん治療向け世界初のCAR T細胞療法製品「Satri-cel」の承認を発表
Observatory.[3] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-32.
More news about: CARsgen Therapeutics
Jun 24, 2026, 09:00 ET Teaching Strategies Named Finalist for Three 2026 CODiE Awards
development, and family engagement solutions. Teaching Strategies has the only evidence based early childhood comprehensive system of curriculum, assessment, PD and family engagement, validated just this year by an ESSA Tier 1 level RCT. Its flagship products, The Creative Curriculum® and GOLD®, reach about 4.5
More news about: Teaching Strategies
Jun 23, 2026, 08:21 ET 카스젠, 고형암 대상 세계 최초 CAR T세포 치료제 사트리셀 승인 발표
[3] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-32.
More news about: CARsgen Therapeutics
Jun 23, 2026, 03:00 ET Power Metallic reports New Lion drill intercepts of 13.30 Meters of 3.98% CuEqRec¹ in Hole 26-115 and 5.26 Meters of 8.45% CuEqRec¹ in Hole 26-105 at Lion
These holes did intersect the favourable mineralized structure, but had low grade assays, including individual assays of up to 0.57% Cu and 1.22 g/t Pd. The fact that these holes are within a few 10s of meters of very high grade intersections is important for the continuing exploration in the Lion area.
More news about: Power Nickel Inc.
Jun 22, 2026, 21:01 ET Ofertas especiales de Beelink en el Amazon Prime Day 2026: ¡hasta un 20% de descuento!
almacenamiento y conectividad adicional. Mate mini está diseñado específicamente para Apple Mac mini, mientras que Mate Pro, que añade características como carga PD de 96 W, comunicación por voz y un altavoz Bluetooth integrado, está diseñado para portátiles.Desde la productividad diaria y el entretenimiento
More news about: BEELINK
Jun 22, 2026, 21:00 ET Beelink 2026: Mega-Sale am Amazon Prime Day - Bis zu 20 % Rabatt
zusätzliche Anschlussmöglichkeiten. Der Mate mini ist speziell auf den Apple Mac mini zugeschnitten, während der Mate Pro – der unter anderem 96-W-PD-Ladefunktion, Sprachkommunikation und einen integrierten Bluetooth-Lautsprecher bietet – für Laptop-Nutzer konzipiert ist.Von alltäglicher Produktivität
More news about: BEELINK
Jun 22, 2026, 20:58 ET Méga-soldes Beelink 2026 à l'occasion de l'Amazon Prime Day : jusqu'à 20 % de réduction
Mate mini est spécialement conçu pour le Mac mini d'Apple, tandis que le Mate Pro, qui intègre des fonctionnalités supplémentaires telles que la recharge PD de 96 W, la communication vocale et un haut-parleur Bluetooth intégré, est destiné aux utilisateurs d'ordinateurs portables.De la productivité
More news about: BEELINK
Jun 22, 2026, 15:07 ET SystImmune Announces First Approval of Iza-bren for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma in China
option for patients with recurrent or metastatic nasopharyngeal carcinoma (NPC) who have progressed following prior platinum-based chemotherapy and PD-1/PD-L1 inhibitor therapyREDMOND, Wash., June 22, 2026 /PRNewswire/
More news about: SystImmune, Inc.